4th Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for AVANIR PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General Medicare coverage of pharmaceutical drugs and Medicare quality programs. Medicare coverage of pharmaceutical drugs and FDA-approved label wording.

LobbyistCovered position, as disclosed
MARTIN A CORRY —
KELLY L. DELMORE —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Health Issues HCR

FDA labeling of pharmaceuticals, general pharmaceutical issues and monitoring of 21st Century Cures Initiative.

LobbyistCovered position, as disclosed
MARTIN A CORRY —
KELLY L. DELMORE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.